Omrix Biopharmaceuticals, Inc. 4
4 · Omrix Biopharmaceuticals, Inc. · Filed Jun 29, 2007
Insider Transaction Report
Form 4
Horowitz Bernard
Director
Transactions
- Exercise/Conversion
Common Stock
2007-06-29$12.27/sh+2,750$33,743→ 8,467 total - Exercise/Conversion
Stock Option
2007-06-29−2,750→ 8,250 totalExercise: $12.27From: 2007-06-27Exp: 2016-06-27→ Common Stock (2,750 underlying)